WellPoint Loses $110 Million on California Individual Business

January 31, 2011

WellPoint chief executive officer Angela Braly said in a conference call with Wall Street analysts last week that her company lost $110 million in the individual health insurance business in California in 2010. 

“We have recently filed additional rate increases for that market,” she said, adding, “We ultimately believe that appropriate rate increases will be approved and obtained in order to maintain the sustainable market for individual members in California.”

Add this to the debate over whether the company was justified in seeking rate increases in the state.


Quote of the Day: Wayne DeVeydt

January 31, 2011

WellPoint chief financial officer Wayne DeVeydt during the company’s fourth-quarter 2011 earnings call.

We continue to believe that underlying medical trend will increase in 2011, and we are reflecting this assumption in our pricing.


Quote of the Day: Carl McDonald

January 24, 2011

Equity analyst Carl McDonald of Citi on UnitedHealth Group’s stock price:

Utilization will have to remain at its unusually low level in order for United’s stock to maintain its 11x multiple — With the market trading at 13.6x, United is now at less than a 20% discount. This makes some sense if volumes stay low, but the discount is harder to justify in an era of minimum MLRs, premium rate regulation, deteriorating Medicare margins, and the pressure exchanges will likely put on commercial margins in the future.


Dental Plans See Continued Shift to Voluntary Benefits in 2010

January 24, 2011

The continuing shift to voluntary benefits was the main story in the dental insurance market in 2010, as insurers struggled to strike a delicate balance between affordability and providing meaningful benefit packages to members, according to the latest issue of Health Plan Market Trends Letter. An MTL tally shows total membership in 2010 up about 1% to 67.677 million among eight leading plans. According to the National Assn. of Dental Plans, dental insurance enrollment in 2009 declined – dropping 5.7%.  NADP reports that about 166 million Americans have some form of dental coverage. NADP reports a continue trend toward dental PPO plans and continued movement away from dental HMOs and indemnity plans.


Blue Shield-CA Takes Turn in Hot Seat Over Premiums

January 18, 2011

Blue Shield of California remains in the hot seat concerning individual rate hikes averaging 15% annually for 2010 and 2011; in some cases the rate of increase is as high as 59%.  The increases impact 194,000 individual plan members.  Blue Shield notes that despite the increases, its individual plans will lose $10 million to $20 million in 2010 and another $20 million to $30 million in 2011. 

The hikes are in line with cost trends, Blue Shield says, noting that the price of medical services is rising 7% annually, utilization is up 5%, and the health plan’s share of costs is up 3%.  Specifically, Blue Shield says, hospital costs rose nearly 15% in 2010, drug costs 12% and physician costs 9%.  Similar increases are expected in 2011. 

In accordance with state law — and following a public outcry — Blue Shield announced it had hired a third-party actuary to review the increases and make public the findings.  The actuary — David Axene – embarrassed WellPoint last year by finding a significant error in the company’s justification for requesting rate hikes of up to 39%.  WellPoint had to reduce the rate of increase.

While agreeing to a third-party review, Blue Shield didn’t agree to a request by California Insurance Commissioner David Jones to delay the increases until March 1 to give the state time to conduct its own review. Jones doesn’t have authority to reject the rate hikes; however, he says his office will still conduct a review.

It seems to me Blue Shield has struck the correct balance.  If Axene finds the increase aren’t justified, the company has agreed to make refunds.  If he finds the increases are justified, it’s pretty hard to question his credibility.


HealthParterns, Lowes, Sanford Health Join ACO, Medical Homes Conference

January 14, 2011

The 2nd annual ACOs, Medical Homes and Health Plan Partnerships conference, Friday, March 25, 2011, in New York City, is shaping up to be an information-packed day. 

Among the speakers: 1. Ruth Krystopolski, president of Sanford Health Plan, who will discuss how her organization has successfully worked with risk sharing and capitation for years; 2. Bob Ihrie, senior vice president of benefits for Lowes Companies, a top human resources executive who is going to talk about his company’s direct contracting relationship with Cleveland Clinic for heart surgery.  3. Babette Apland, senior vice president of health and care management for HealthPartners, who will assess the opportunities and pitfalls of changes to the delivery system envisioned by reform. 

Featured Speakers:

Babette Apland, SVP, Health and Care Management, HealthPartners
William Gillespie, M.D., Chief Medical Officer, EmblemHealth
Dennis Horrigan, President and CEO, CIPA WNY IPA Inc.
Bob Ihrie, SVP, Benefits, Lowes Companies
Ruth Krystopolski, President, Sanford Health Plan
Carl Mercurio, President, Corporate Research Group


Why IT Will Rule the Future of Health Plans

January 13, 2011

It is my view that managed care information technology will play an increasingly important role in the future survival and success of health plans.  That’s why I’m happy to announce such a strong agenda of speakers for our second annual Next Generation in Managed Care IT conference, Monday, March 28, 2011 in New York City.  (Yes, I know, this is basically an ad I’m writing here; but last year’s event was sold out, so I thought I’d give you all a heads up).

Here’s the line-up of speakers and the agenda.  I’ll be moderating the day’s proceedings.  (Despite that, you really should attend; it’s going to be an information-packed day).  Click here to register.

Keynote Speakers

Joseph Brand, Chief Technology Officer, Horizon BCBS of New Jersey

Meg McCarthy, EVP of Innovation, Aetna Inc.

Bill Wray, CIO, BCBS of Rhode Island

 

Featured Speakers

Anne-Marie Audet, VP, Quality, Improvement , Efficiency, Commonwealth Fund

Peter Goff, Acting Senior Director, IT, Alameda Alliance For Health

Pamela Larson, Director, Consumer Health, Kaiser Permanente

Tom Lutzow, CEO, Independent Health Plan

Carl Mercurio, President, Corporate Research Group

John Moore, Managing Partner, Chilmark Research

Jeffrey Pankow, Director IT, Excellus BCBS

Troy Stillwagon, Director of Information Systems, Scott & White Health Plan
Jessica Zabbo, Provider Technology Supervisor, BCBS of Rhode Island 


Quote of the Day: Sen. Lamar Alexander (R-TN)

January 10, 2011

Sen. Lamar Alexander (R-TN) on political rhetoric following the attempted assassination of Rep. Gabrielle Giffords (D-AZ):

We ought to cool it, tone it down, treat each other with great respect, respect each other’s ideas, and even on difficult issues like immigration or taxes or the health care law, do our best not to inflame passions.

(Hat tip: Politico)


Quote of the Day: Executive Office of the President

January 7, 2011

From the White House Executive Office of the President statement alerting House Republicans that President Obama will veto legislation aimed at repealing healthcare reform, specifically H.R. 2, The Repealing the Job-Killing Health Care Law Act:

The Administration strongly opposes House passage of H.R. 2 because it would explode the deficit, raise costs for the American people and businesses, deny an estimated 32 million people health insurance, and take us back to the days when insurers could deny, limit or drop coverage for any American.


Outlook for Managed Care 2011: Lower Profits in Transition Year

January 7, 2011

Things look rather dodgy for health insurers in 2011 and beyond. 

Healthcare reform will take a big bite out of industry profits.  The industry is struggling with longer-term challenges like the continued erosion of fully funded commercial membership – which generates a significant chunk of industry profits.  And plans appear to be at or near the top of an insurance underwriting cycle that has helped boost profits significantly. 

Plans like UnitedHealth and Humana have already said profits will be down considerably in 2011.  Others are still assessing the impact reform will have on products, services and margins.  “It’s such a frustrating time,” says HealthPartners chief executive Mary Brainerd.  “The changes are rolling out piecemeal,” she adds.

That makes 2011 a transition year.  Health plans will feel the first real sting of reform – including the implementation minimum medical cost ratio requirements, the first wave of billions of dollars in new taxes, Medicare cuts and benefit mandates.  Longer term, plans must adjust to other changes – including the commoditization of the individual and small group markets through health insurance exchanges beginning in 2014.

Plans have made clear what they believe to be the formula for continue success: reduce administrative costs, diversify into new lines of business, squeeze brokers and providers, and invest in technology to better manage risk and care.  Getting there will be no small task.  (And if you’re waiting for reform to get repealed or significantly scaled back, don’t hold your breath).  Complete coverage appears in our annual report The Outlook for Managed Care 2011.


The Facts on Healthcare Reform

January 6, 2011

Click here for a handy “Factbox” from Reuters listing the basic provisions and timeline for healthcare reform.  When presented like this – without spin from liberals or conservatives – the benefits of the legislation to average Americans really jump out.  That’s why I think Republicans will fail in their attempts to repeal or scale back the law.  People are going to realize there’s a lot of good stuff in here for them.  Or as former GE chief Jack Welch summed it up: “Freebies are now coming my way.”


mHealth in 2011?

January 6, 2011

mHealth is #49 on JWT’s list of 100 Things to Watch Out for in 2011 (Hat tip: Infectious Greed), right between #48 Matcha (i.e., Japanese green tea powder, which isn’t nearly as unpalatable as natto, but still not high on my list of treats) and #50 Michael Jackson Lives On.  Notes JWT:

Look for mobile health apps to help improve health care and change the way patients and their physicians interact (think doctors using smartphones to access patients’ medical histories, patients monitoring their own blood pressure and glucose levels)….With 500 million people forecast to be using mobile health apps by 2015, global opportunities in this market are valued at as much as $60 billion.

I’ll watch.  But with mobile browser usage at just 3% of total browser usage — and healthcare a subset of that — my guess is 2011 is way too early for mHealth.  Of course, given that I still can’t figure out if my mobile phone has a speakerphone feature, perhaps I’m not the best guy to make this call.


NCPA on CVS Caremark — Then and Now

January 6, 2011

Here’s what the National Community Pharmacists Assn. had to say on its blog Nov. 2, 2010 about CVS Caremark:

Community pharmacists and consumer groups have long argued and continue to maintain that the merger of the giant retail chain pharmacy CVS with Caremark, a major pharmacy benefit manager (PBM), has apparently compromised health care outcomes, reportedly driven up costs for payers and robbed consumers of fair competition on a level pharmacy playing field.

And here’s what NCPA chief executive Kathleen Jaeger had to say in an email regarding the CVS Caremark announcement that it was acquiring the Medicare Prescription Drug Plan business of Universal American, which has an exclusive arrangement to market NCPA’s Community Care Rx PDP product:

We understand that CVS Caremark is committed to maintaining the same plan design that Universal American…has had with independent community pharmacies for at least the next two years, including no mail order component….That’s two years from now – so, right now, we are dealing with the status quo.

NCPA’s lack of love for CVS Caremark is no secret.  What isn’t clear is how much money NCPA makes off the CCRx arrangement.  “I was frankly surprised at how little financial benefit NCPA receives,” says Pembroke Consulting president Adam Fein.  Still, Fein wonders on his DrugChannels blog, “Will the alliance reduce NCPA’s anti-CVS lobbying to Congress and the FTC, thereby lessening political pressure on CVS Caremark?”


To Slow Healthcare Spending Growth, Destroy the Economy

January 6, 2011

Healthcare expenditures in the U.S. rose 4% in 2009, according to CMS, the slowest rate of increase since the government began tracking spending 50 years ago.  CMS attributed the slowdown in large part to the recession.  Conclusion: We finally have figured out how to slow healthcare spending growth — tank the economy.  Actually, that doesn’t really work either because healthcare expenditures as a percentage of GDP jumped 100 basis points to 17.6% in 2009 — the largest one-year increase in 50 years. 

Not surprisingly, during the recession, healthcare spending by Medicaid rose a whopping 9% — with the federal government taking on a larger share of the burden.  In fact, federal government spending on Medicaid rose 22% in 2009, compared to a 10% decline in state Medicaid spending.  Meanwhile, out-of-pocket spending by consumers rose just 0.4%.  Spending by private insurance companies rose just 1.3%, reflecting a decline in enrollment.


CVS to be 2nd Largest Medicare Part D Plan

January 3, 2011

Based on current enrollment (see chart below), CVS Caremark (Woonsocket, RI) will become the nation’s second largest Medicare Prescription Drug Plan following the acquisition of the Part D business of Universal American (Rye Brook, NY) for $1.25 billion.  The figures in the chart are as of November 2010 and don’t reflect 2011 open enrollment or auto assignment of dual eligibles.

Note (Jan. 5, 2011): The data in this analysis is for Prescription Drug Plan (PDP) lives only and doesn’t include Medicare Advantage Part D (MA-PD) membership.


The Downside of Living Longer

January 3, 2011

A new paper from The Journals of Gerontology finds that Americans may be living longer, but longevity comes with a price: a longer life span means living longer with disease.  As the chart below suggests, and as noted in the New York Times: “A 20-year-old man today can expect to live about a year longer than a 20-year-old in 1998, but will spend 1.2 years more with a disease, and 2 more years unable to function normally.”  (Hat Tip: Infectious Greed).  In other words, we’re doing a good job of helping people live longer with disease; but we’re not doing as well preventing the onset of disease.  The study, by Eileen Crimmins and Hiram Beltrán-Sánchez, notes:

Between 1950 and 1970 most of the decline in mortality rates from CVD [cardiovascular diseases] was due to prevention (Goldman & Cook, 1984), whereas acute disease management and medi­cal treatments accounted for about half of the decline be­tween 1980 and 2000 (Ford et al., 2007). Cancer mortality decline also has resulted from a combination of the same fac­tors. For instance, lung cancer is primarily declining because people have reduced smoking, whereas breast, prostate, and colon cancer mortality is reduced because of increased screening, early diagnosis, and new treatments regimens. It is only the decrease in disease onset due to primary prevention that is clearly going to be related to longer disease-free life. Where reduction in mortality occurs because of longer sur­vival with disease, the length of life with disease is increased. 

Source: Journals of Gerontology

For me, the study illustrates why it’s so difficult to prove return-on-investment for disease management and wellness programs.  Yes, these programs improve outcomes, but there’s scant evidence of cost savings.  That makes sense if all we’re doing is helping people live longer with disease.  Even if we’re helping people avoid disease, we won’t be able to measure the return until years down the road.  As the study notes:

The cost of maintaining and providing care for a longer lived–older population is an important part of determining the economic well-being of countries with established so­cial security and government-provided health services. Even if the length of disabled life stays roughly the same but the length of life needing treatment for disease increases, lifetime health costs will increase unless the cost of health care is reduced. Recent increases in Medicare spending in the United States appear to be highly related to this increase in treatment of diseases.

This isn’t to say wellness and disease management programs are bad.  In fact, I’m a big believer.  It’s just that caring for people costs money.  The longer we live, the more it costs.  The only question is who picks up the tab and when.


Follow

Get every new post delivered to your Inbox.

%d bloggers like this: